Introduction
of vasculopathy in both adults and children with HIV remains a matter of debate by scientists [7] . However, studies have mentioned the direct infection by HIV1 virus, immune complex deposition, and impaired regulation of the immune response as likely causes [8] . While the strength of the asso ciations and the pathogenic mechanisms remains a matter of debate, autopsy studies evaluating the cerebral vasculature in HIVinfected patients demonstrate a variety of patholog ic changes. Small vessels appear to develop a vasculopathy, with perivascular space dilation, infarction, pigment depo sition, vessel wall mineralisation, and perivascular cell in filtrates, all without evidence of a vasculitis [6] , but recent studies have implicated inflammation as a course of vascular disease in the central nervous system (CNS) [9, 10] . In larg er cerebral vessels, progressive vessel dilation occurs in HIV infection, potentially mediated by a thinner media layer leading to aneurysm formation [11] . Additionally, there is evidence for increased arterial inflammation and carotid atherosclerosis in the setting of HIV infection [9, 10, 12, 13] . These vascular changes could certainly disrupt cerebral au toregulation, diminish vessel wall tensile strength, and dis rupt blood-brain barrier function, resulting in an increased risk of stroke. Although the biological mechanisms under lying the increased risk of ICH and IS in HIVinfected indi viduals likely overlap, there may be distinct mechanisms for each stroke subtype that are populationspecific or manifest in the presence of other medical conditions and traditional stroke risk factors [14] .
Furthermore, researchers have demonstrated that immu nosuppression secondary to HIV can predispose to opportu nistic infections in the CNS. These AIDSdefining infections include toxoplasmosis, cryptococcal meningitis, tubercu losis, cytomegalovirus, and progressive multifocal leuko encephalopathy (PML) secondary to JC virus reactivation, which can also present as cerebrovascularlike manifestation in HIV patients [15] . It is well known that HIV traverses the bloodbrain barrier because the virus has been detected in the cerebrospinal fluid and brain parenchyma on brain bi opsy [16] , but the association between HIV and cerebrovas cular diseases is still a matter of debate.
In view of several controversies associated with the pathogenesis of HIV and cerebrovascular diseases, we review published data on the association between HIV and CVDs. We looked at the association between varies types of stroke (ischaemic and haemorrhagic), vasculopathies, opportu nistic infections leading to stroke in children, as well as ra diological findings described in HIV and stroke patients. We used a universal search engine (Google Scholar) to search for scholarly publications on cerebrovascular diseases and HIV/ADIS.
HIV opportunistic infections causing stroke
Studies have indicated that vasculitic changes in intra cerebral vessels associated with IS can be due to diverse op portunistic infections such as tuberculosis, cytomegalovirus infection, varicellazoster infection, herpes simplex infec tion, syphilis, cryptococcosis, candidiasis, aspergillosis, mu cormycosis, coccidioidomycosis, and trypanosomiasis [17] . Several cases of lymphomatoid granulomatosis and malig nant lymphoma have also been associated with infarcts [17] . Stroke as a manifestation of HIV infection is poorly char acterised [18, 19] . This is primarily because most HIV pa tients presenting with a clinical picture suggestive of stroke are more likely to have an underlying focal or diffuse CNS infection or tumour responsible for their symptoms [19] .
HIV and CNS vasculopathy
HIVassociated vasculopathy encompasses different clin ical phenotypes, including largevessel aneurysmatic disease and mediumvessel occlusive disease with or without fusi form dilation or stenosis ( Fig. 1 ) [20] . HIVassociated cere bral vasculopathy was proposed as an important mechanism of stroke in the absence of a known cause, possibly related to deposition of a circulating immune complex or a direct toxic effect on the vascular endothelium [21] . The vascular histopathological changes in HIVinfected patients include medial fibrosis, loss of muscularis with destruction of the in ternal elastic lamina, and intimal hyperplasia [7] . Gutierrenz et al. in their study indicated that, patients with HIV infec tion have a thinner media to wall thickness ratio (MWR) than unaffected control subjects within the same age group; however, they excluded control subjects with different age groups [22] . Because none of the affected cases had a stroke, which suggests that the thinning of the media could be a pre clinical stage in the occurrence of clinical CVDs in patients with HIV [22] . A thinner media has been reported in enti ties associated with arterial dilatation in patients with and without HIV [7, 20, 23, 24] . Some authors consider a more restrictively defined clinical syndrome, consisting of aneu rysmal disease, termed aneurysmal vasculopathy [25] .
Disruption of the internal elastic lamina (IEL) has been reported in HIV vasculopathy [23, 26] , but this finding was not further investigated. Therefore, we propose further stud ies in this direction. Some authors suggest that IEL disrup tion is usually encountered in flowmediated dilation [27] . The smooth muscle cells that form the media layer can be di rectly infected with HIV with progressive damage of the me dia with the aid of classical atherosclerosis and inflammation ( Fig. 1 ) [28] , although some endothelial role in the expres sion of metalloproteinases (MMPs) has also been suggest ed [29] . These findings suggest that in patients with HIV without clinical stroke, there is thinning of the media arte rial layer, and thinning of the media could be a preclinical stage in the development of HIV vasculopathy. Guedes et al. describe an HIV+ patient with HIVassociated vasculopa thy, who developed both IS and subarachnoid haemorrhage (SAH). Vasculopathy was imputed to CNS HIV compart mentalisation when treatment consisted of highdose ste roids followed by antiretroviral therapy (ART) adjustment to improve clinical penetration effectiveness (CPE) and vascular abnormalities improved alongside nearnormalisa tion of CSF viral load on followup evaluation [30] .
Studies have demonstrated leukocytoclastic vasculitis (LV) of the vasa vasorum in extracranial carotid arteries and intimal abnormalities in intracranial mediumsized ves sels, and have hypothesised a breakdown of the blood brain barrier (BBB) as a cause for small vessel disease ( Fig. 1 ) [6, 20, 31] . The vasculopathy may be asymptomatic and result in stroke, encephalopathy, cognitive impairment, or nonspe cific neurological symptoms. Cutfield et al. advise a sensible approach to the management of HIVassociated vasculopa thy with thorough investigation to exclude other infectious causes and autoimmune vasculitis [32] . Autopsy studies conducted by Connor et al. indicated that none of their cases showed evidence of vasculitis. Smallvessel occlusion was not observed, with the exception of one possible intra vascular thrombus in a small penetrating artery in the basal ganglia of two cases and in a single neocortical penetrating artery in five cases. Fibrinoid necrosis of occasional neocor tical and basal ganglia microvessels was a feature only in six cases; one brain was unusual in that it showed severe agonal global hypoxicischaemic damage [6] .
Inflammation as pathogenesis of stroke in HIV
Although the sources of inflammatory cells in the ad ventitia of those with HIV is not clear, it is well known that the brain arteries are wrapped by the leptomeninges as they enter the skull, hence association with aseptic meningitis and adventitial inflammation seems plausible. It is now clear that inflammatory cells (macrophages and/or lymphocytes) are frequently reported in the arterial wall of in vitro and in vivo specimens with HIV with atherosclerosis [28, 33] . Research ers have also demonstrated concrete evidence of inflamma tion in HIV models of atherosclerosis (animal and human) and indicated that inflammation plays an important role in the pathophysiology of vascular disease. Further studies [28, 33, 34] . Studies have also indicated that HIV infection per se may contribute to cardiovascular disease (CVD) risk via nonspecific inflammation. Uncontrolled HIV infection is associated with elevated markers of inflammation, including Creactive protein (CRP); levels of these markers decline with treatment but may or may not return to normal levels [35] , and analysis from the FRAM study cohort has shown that fibrinogen and CRP are strong and independent predictors of mortality in HIVinfected adults even in those with rela tively preserved CD4 counts > 500 cells per microliter [36] . Gutierrez et al. in their study confirmed that HIV+ cases had a higher inflammation score than HIV-cases, but this difference was mostly driven by a significant difference in ad ventitial inflammation in HIV+ cases while intima inflam mation was progressively more intense and widespread as the atherosclerotic phenotype evolved, but this effect was in dependent of HIV status. They indicated that inflammation in the media was typically observed in the context of intima inflammation [9] . Their study further indicated that in HIVcases as compared to HIV+ cases, intima inflammation was also the most important predictor of adventitial inflamma tion. They further argue that brain arteries in HIV+ cases ap peared to have enhanced susceptibility to the development of adventitial inflammation compared with HIV-cases who have independent atherosclerosis or intimal inflammation. They therefore concluded that there is a strong association between HIV-and adventitial inflammation [9] . They also observed that contrary to what was seen in HIV-cases, ad ventitial inflammation in HIV+ cases were not entirely ex plained by associations with intimal inflammation because of atherosclerosis. It is also important to note that adventitial inflammation could be a predictor of dolichoectasia in arter ies with a thin media, which supports the notion that HIV vasculopathy is a form of pathological brain arterial remod elling observed predominantly in HIV cases with persistent immunosuppression, in which adventitial inflammation is a surrogate of immunosuppression or a marker of the un derlying pathophysiology leading to thinning of the media and subsequent arterial dilatation [9, 10] . 
HIV and ischaemic stroke
Qureshi et al. in a retrospective casecontrol study in dicated that HIV1 infection was particularly associated with the occurrence of ischaemic stroke after adjustment of several cerebrovascular risk factors [37] . Studies have also indicated that the total prevalence rate of strokes in HIV patients is 1.9% with ischaemic stroke accounting for 1.2% whatever the age and the prevalence for juvenile ischaemic strokes occurring under the age of 46 years was 1.6%, high er than in the HIVnegative population [38] . It is now clear that stroke patients are older, with lower CD4 cell count, and are in more advanced stages of the disease than infected patients without stroke [38] . Further studies have indicated that the majority of African American patients suffer isch aemic strokes, with small vessel occlusion being the most common stroke subtype followed by large vessel occlusion, cardio embolic, watershed, and cryptogenic [39] . Studies has further emphasized that HIV caused vasculitis of the carot id arteries in patients and this eventually led to the forma tion of hypoechogenic plaques and consecutive stenosis [40, 41] . Several causative mechanisms have been proposed for the relationship between HIV infection and cardiovas cular risk including HIVassociated dyslipidaemia (Fig. 2) , endo thelial dysfunction (Fig. 1), inflammation (Fig. 1) , and hyper coagulability (Fig. 2) [42] .
HIVinfected patients tend to have decreases highden sity lipoprotein cholesterol (HDLc) and lowdensity lipo protein cholesterol (LDLc) levels, followed by an increase in plasma triglyceride levels prior to developing AIDS, and the degree of viremia may correlate with the amount of tri glyceridaemia [42] . A prospective study of 50 men from the Multicentre AIDS Cohort Study has shown significant declines in mean serum total cholesterol (TC), HDLc, and LDLc [43] , and subsequent initiation of ARTs was as sociated with increases in TC and LDLc but little change in HDLc (Fig. 2) (it is noteworthy to mention that TC and LDLC were observed after about three years of ART, which possibly represents a return to preinfection serum lipid lev els after accounting for expected agerelated changes) [42] . An increased pulse wave velocity (which may be an early marker for atherosclerosis) has been noted in two small stud ies of HIVinfected patients taking ARTs compared to HIV seronegative controls [44] . Endothelial function was assessed by brachial artery flow mediated dilation (FMD) in treat mentnaive patients initiating ARTs with either a protease inhibitor (PI)based, nonnucleoside reverse transcriptase inhibitor (NNRTI)based, or nucleoside analoguesparing regimen [45] . Rapid and significant improvement in FMD was seen in all treatment arms compared to baseline, sug gesting that suppression of HIV and not the specific drugs themselves led to improved endothelial function [45, 46] . However, antiretroviral medications may independently contribute to endothelial damage [42] .
Otedo et al. presented eight cases of central nervous sys tem and peripheral arteritis in HIV patients with low cluster of differentiation 4 (CD4) counts (2200 per dl) [47] . Next to the HIV infection itself, treatment with highly active an tiretroviral therapy, especially with protease inhibitors, may increase serum cholesterol and thus promote cerebrovas cular disease in HIVinfected patients [48] . Several studies have also described elevated plasma levels of endothelial cell products, including von Willebrand factor (vWF) and soluble thrombomodulin (sTM) in those living with HIV (Fig. 2) [49] . sTM was strongly raised in those patients with the lowest CD4+ cell count, but levels of vWf increased at each incremental fall in CD4 cell count. A positive correlation has also been noted between HIV viral load and prothrombin fragment in 90 HIVinfected young individuals with CD4 cell count 216 ± 198 not receiving ARTs, suggesting that in creasing levels of viraemia may increase the risk of throm bosis [50] . Furthermore research has shown the deficiency of protein C and S in HIV patients (Fig. 2) [51] . Although acute thrombosis lowers the levels of protein C, protein S, and antithrombin (Fig. 2 ) and the initiation of Warfarin lowers the levels of protein C and protein S, normal values rule out those factors as risk factors for hypercoagulability in these patients [42] .
HIV and haemorrhagic stroke
Research has indicated that ICHs are mainly localised in the subtentorial regions although their localisations can vary and are sometimes multiple. While small sized ICH could be asymptomatic, their mortality rate tends to be high [52] . A subdural haematoma was reported in an HIV1infected patient with an HIVassociated en cephalopathy and cerebral atrophy [53] . However, intrace rebral haemorrhage is a rare, late, and serious complication of AIDS with a mortality rate of 62.5% [54] . Some studies have indicated that haemorrhagic strokes accounted for 25% of all strokes and that comprise of intraparenchymal and subarachnoid [55] . While it is clear that vasculitis is usually found in small veins, cerebral venous thrombo sis is very rare in HIV1 infection [56] . It was noted that extensive intracranial sinus thrombosis was also the con sequence of a hypercoagulable state complicating AIDS associated nephrotic syndrome [57] .
Studies have also indicated that cerebral arteriovenous malformation (AVM), although rare, might be considered in the differential diagnosis of acute cerebral haemor rhage in patients with HIV within the proper context, and prompt a proper diagnostic and therapeutic approach [58] . This was proposed by Alomari et al., who noted an un usual presentation of AVM in one case during their study. In attempts to explain the unusual presentation, they indi cated that: 1) the presence of multiple cerebral AVMs is rare, 2) the occurrence of multiple episodes of cerebral haemor rhage secondary to multiple microAVMs has never been reported before in HIV, and 3) most of the cerebrovascular complications in the literature were reported in patients with advanced immunosuppression [58] . Their patient maintained a moderate immunosuppression status while receiving triple ART without signs of AIDS. They argue that in contrast to the multiple cerebral AVMs seen with hereditary haemorrhagic telangiectasia, which are super ficially located within the cerebral cortex and are not as sociated with haemorrhage or venous pouches, the lesions encountered in their patient were deeply situated lesions within the cerebral parenchyma and developed multiple haemorrhages [58] .
HIV and stroke in children
Park et al. described seven HIV+ children with clinical and/or neuroradiological evidence of stroke and estimated the clinical incidence of cerebrovascular events to be 1.3% per year [59] . Another study of 380 HIV+ children found that 1% had radiological evidence of a stroke [60] . In chil dren, the risk is primarily related to coagulopathy, cardio embolism, vascular ectasia or aneurysms, subacute necro tising encephalopathy, and arteriopathy [61, 62] . Kure et al. demonstrated the presence of HIV within the arterial wall of the circle of Willis and in the cerebral parenchy ma in a child who died of HIVrelated cerebral vascular ectasia and multiple infarcts [63] . Schieffelin et al., with 51 subjects with diagnoses suggestive of CNS vasculop athy among the 3338 HIV+ subjects and after review, excluded 27 as not being consistent with CNS vasculop athy [64] . They indicated that despite being a rare event, the incidence rate of stroke is higher than the reported incidence rate of stroke in the general paediatric pop ulation, so they concluded that there is increased in cidence of cerebrovascular events in HIV+ children, with the incidence among the HIV+ subjects being 2.4 times that of HEU subjects [64] .
Whereas aneurysms of the great vessels can occur in the adult HIV population, CNS vasculopathy is more common in the paediatric population [65, 66] . In paediat ric HIV patients, aneurysms are characteristically diffuse, fusiform dilatations of the larger arteries around the Circle of Willis [7, 61] . Some authors have suggested that the in flammation related to CNS vasculopathy, and aneurysm formation in particular, may result from coinfections in im munocompromised individuals [67, 68] . The possibility that CNS vasculopathy results from an inflammatory response to HIV in the CNS has also been suggested [63, 69] . There is evidence that HIV invades the CNS early in perinatal infection [6, 70] . HIV DNA has been identified in the cere bral white matter and basal ganglia as well as in blood vessel walls [60, 71] . A transient cerebral arteriopathy caused by a variety of infectious agents, including HIV, is found in chil dren [72] . This typically presents with infarction in the ter ritory of the lenticulostriate vessels associated with arteri opathy of the distal internal carotid artery, proximal middle cerebral artery, or anterior cerebral artery. The diagnosis requires followup imaging showing improvement in the ar terial stenosis. However, transient cerebral arteriopathy has not been described in adults and is unlikely in these patients given the distribution of their brain lesions and protracted clinical course [73] .
Radiological findings of HIV patients with stroke
Cole et al. with radiological studies demonstrated that AIDS is strongly associated with both IS and ICH although available angiographic investigations showed no evidence of vasculitis [14] . A study conducted with transcranial Dop pler comparing HIVinfected patients and healthy control subjects excluding patients with preexisting stenotic or oc clusive lesions indicated that HIVinfected patients had re duced baseline cerebral blood flow and decreased cerebrovas cular reserve capacity in response to acetazolamide challenge, suggesting altered vasoreactive responses in HIV infection [5] . Other studies are of the view that except for studies based on both clinical and pathological evidence, it is quite difficult to isolate strokes caused by intrinsic AIDSassociated patho physiology in the absence of AIDSrelated medical complica tions or other concomitant aetiologies [74] . This was reported in a populationbased study to directly quantify the AIDS associated risk of stroke, which attempted to address the pos sibility that pathophysiological mechanisms intrinsic to AIDS may predispose to stroke [74] .
Further studies have indicated that in HIV patients presenting with acute stroke with corresponding neurora diology findings, the most common lesions were segmental narrowing and dilatation of major cerebral arteries, basal ganglia infarction, and cortical atrophy [75] . Brain imaging studies have also shown right anterior corona radiata and basal ganglia acute infarction, more clearly shown on brain MRI with contrast [42] . Maggi et al. examined the ultrasonic structure of plaques in HIVpositive patients compared to those of atherosclerotic and inflammatory origins [76] . They found that carotid plaques of HIVinfected patients share several Duplex sonographic characteristics, e.g. the iso or hypoechogenic plaque morphology, with those found in ca rotid arteritis, and hence concluded that arteritis, but not arteriosclerosis, causes carotid artery disease and stroke in HIV infected patients [76] .
Conclusions
Although several causative mechanisms have been proposed for the relationship between HIV infection and cerebrovascular diseases, including HIVassociated dyslipi daemia, endothelial dysfunction, inflammation, and hyper coagulability, the pathogenesis of HIVvasculopathy is not completely understood. Besides all the pathological entities discussed above, HIV itself has been implicated in the patho genesis of cerebrovascular diseases, either through direct invasion and vessel wall destruction or cytokinemediated vascular remodelling. Despite sparse evidence on the role of vasculitis in the pathogenesis of HIVassociated vascu lopathy, with few autopsy studies, HIVparticles or proteins have been demonstrated in vessel walls of a single paediat ric patient, but some researchers still do not support this fact. In view of controversies in the association between the pathological association of HIV/ADIS and cerebrovas cular disease, we noted a strong link between the two patho genic processes. We propose further studies be conducted on some of the antiretroviral medications because some them lead to vascular abnormalities.
